Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma, Non-Hodgkin 3Neoplasms 2Lymphoma 2Lung Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Nose Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1

Interventions

Erlotinib Hydrochloride 3Bevacizumab 3Radiotherapy 2Filgrastim 2Cetuximab 2sargramostim 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1enasidenib 1aldesleukin 1Vorinostat 1Tomography, X-Ray Computed 1Thiotepa 1Ritonavir 1Radionuclide Imaging 1Radiation 1Positron-Emission Tomography 1Peripheral Blood Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Irinotecan 1Indinavir 1Ibuprofen 1Hydroxyurea 1Granulocyte Colony-Stimulating Factor 1Gefitinib 1Fluorouracil 1Etoposide 1Epirubicin 1Electrocardiography 1E6 protein, Human papillomavirus type 16 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Esthesioneuroblastoma, Olfactory × Positron-Emission Tomography × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡